Behavioral interventions for antipsychotic induced appetite changes

Area of Science:

• Pharmacology
• Neuroendocrinology
• Behavioral Science

Background:

• Weight gain is a common and challenging side effect of first and second-generation antipsychotic medications.
• Antipsychotic-induced weight gain is linked to increased appetite, making behavioral interventions less effective.
• Current weight management options for patients on antipsychotics are limited.

Purpose of the Study:

• To explore novel interventions for managing antipsychotic-induced weight gain.
• To identify strategies that specifically target the neuroendocrine mechanisms regulating appetite.
• To improve the efficacy of behavioral weight management programs in this patient population.

Main Methods:

• Review of potential interventions targeting appetite regulation.
• Consideration of dietary approaches that do not increase appetite.
• Evaluation of strategies to manage anticholinergic side effects like thirst.
• Assessment of the role of discouraging cannabis use.
• Exploration of metformin as an adjunct therapy.

Main Results:

• Novel strategies may enhance weight management efficacy.
• Dietary modifications, managing thirst, and discouraging cannabis use are potential avenues.
• Metformin may be a beneficial addition to behavioral interventions.

Conclusions:

• Systematic exploration of novel weight management options is timely.
• Targeting specific neuroendocrine factors offers a promising approach.
• Improving treatment options for antipsychotic-induced weight gain is crucial for patient care.